Machine Learning

As AI agents and non-human identities multiply, Hush Security's new platform aims to replace risky static secrets with unified, identity-based access.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

As smugglers take to the sea in high-tech subs, companies like Jeffs' Brands are betting on AI-driven underwater security to turn the tide.

From the founders of thinkorswim, a new AI platform claims you're underpaid by millions and offers tools to prove it. Here's how Lossdog works.

Dr. Mark Leenay joins Cohere Health's board, a strategic move to blend deep clinical and health plan expertise with the firm's advanced AI platform.

A new study of 500+ leaders shows most firms use AI superficially, facing intense ROI pressure, governance hurdles, and a growing talent gap.

An intelligence agency's award-winning success with an AI platform reveals how technology is revolutionizing the fight against complex terror financing networks.

Medtronic's diabetes arm hits the road for its IPO, seeking to raise up to $784M in a major test of investor appetite for specialized medtech firms.

With a fresh $40M in funding, Letter AI is challenging sales tech incumbents by moving beyond static playbooks to real-time, deal-specific AI guidance.

Hyperlink InfoSystem unveils AI agents promising to slash operational costs by up to 90%, signaling a major shift in workforce and business strategy.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

Data security firm Druva unveils autonomous AI agents that automate complex investigations, promising a new era of efficiency in cybersecurity operations.

With a promise of cellular renewal via exosomes, (plated) Skin Science is leading a biotech revolution. But can it navigate the hype and regulatory hurdles?

Larimar Therapeutics' nomlabofusp receives Breakthrough Therapy Designation, paving an accelerated path for a potential disease-modifying treatment.

Hunt Energy Network acquires the massive Fort Duncan battery, boosting its Texas portfolio to 420MW and signaling an aggressive expansion in the booming ERCOT market.

The bioprocessing leader posted robust 2025 earnings, outperforming the market with strategic innovation and a major expansion into Asian markets.

The partnership moves beyond compliance, integrating deep binary analysis with lifecycle management to provide continuous software risk intelligence for critical industries.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

Swiss biotech AC Immune begins a human trial for an oral drug aiming to halt the chronic inflammation driving diseases like Alzheimer's and Parkinson's.

With no approved therapies for Hepatitis E, Atea Pharmaceuticals' new drug shows potent preclinical results, offering a potential lifeline for vulnerable patients.